biote Corp. (BTMD): Operating Income

Annual figures by period end, from SEC filings.

$35.55M

Year ended 2025-12-31

$14.75M

Trailing 12 months to 2026-06-30

2021-12-31 Operating Income (USD) 2025-12-31

Period ended	Operating Income	Change YoY	Source filing
2025-12-31	$35.55M	+12.5%	2026-03-13, From 2025-01-01
2024-12-31	$31.61M	+10.3%	2026-03-13, From 2024-01-01
2023-12-31	$28.66M	n/m	2025-03-14, From 2023-01-01
2022-12-31	-$60.72M	n/m	2024-03-15, From 2022-01-01
2021-12-31	$34.56M	n/a	2023-03-29, From 2021-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Income	Change YoY
biote Corp. (BTMD)	2025-12-31	$35.55M	+12.5%
Glass House Brands Inc. (GLAS)	2025-12-31	-$16.53M	n/m
Marimed Inc. (MRMD)	2025-12-31	-$2.82M	n/m
Cronos Group Inc. (CRON)	2025-12-31	-$17.39M	n/m
Natural Alternatives International Inc (NAII)	2026-06-30	-$18.75M	n/m
Jushi Holdings Inc. (JUSH)	2025-12-31	$4.85M	-55.3%
Niagen Bioscience, Inc. (NAGE)	2025-12-31	$16.28M	+110.7%
Mannatech Inc (MTEX)	2025-12-31	-$426.0K	n/m
Fitlife Brands, Inc. (FTLF)	2025-12-31	$10.06M	-23.3%

Compare BTMD, GLAS, MRMD, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗